On a per-share basis, the
The results topped
The clinical testing company posted revenue of
For the year, the company reported profit of
For the current quarter ending in April, IQVIA expects its per-share earnings to range from
The company said it expects revenue in the range of
IQVIA expects full-year earnings in the range of
IQVIA shares have risen nearly 3% since the beginning of the year. The stock has increased 15% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from
Copyright by Automated Insights, Inc. All rights reserved., source